Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home
SECURADOM
1 other identifier
observational
10
1 country
4
Brief Summary
Currently, COVID+ infected patients who are on ambulatory home monitoring self-assess their health status simply by completing questionnaires and measuring their temperature twice a day. The SECURADOM project proposes to facilitate the follow-up of COVID+ or suspected COVID+ infected patients, followed at home, by collecting clinical signs on a telephone application and to monitor physiological safety parameters (respiratory rate, heart rate, temperature, blood pressure, activity) using connected objects developed by the company WITHINGS. This daily monitoring, which can be transmitted by patients to the doctors in charge of their surveillance, will improve the quality and safety of home monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2020
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2020
CompletedFirst Submitted
Initial submission to the registry
September 17, 2020
CompletedFirst Posted
Study publicly available on registry
September 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2021
CompletedMay 20, 2021
September 1, 2020
4 months
September 17, 2020
May 17, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Sensitivity and Specificity of the patient's aggravation with a logistic regression model
The sensitivity and specificity of a logistic regression model based on the vital parameters retrieved from the connected devices will be calculated in order to evaluate its performance
1 year
Sensitivity and Specificity of the patient's aggravation with a cluster model
The sensitivity and specificity of a cluster model based on the vital parameters retrieved from the connected devices will be calculated in order to evaluate its performance
1 year
Secondary Outcomes (2)
Study the evolution of daily patient parameters without aggravation over time
1 year
Subjective assessment of the connected devices
1 year
Study Arms (1)
Covid19 Patients
Patients diagnosed as COVID-19 positive and managed on an outpatient basis.
Interventions
The patient has to measure everyday several vital parameters like respiration and heart rate during the night with Withings Sleep, temperature with Withings Thermo, arterial pressure with Withings Tensiometer and physical activity with Withings smartwatch.
Eligibility Criteria
Patient diagnosed COVID positive with RT-PCR positive or very suggestive symptoms and a contagion (contact with sick subjects) that can be managed on an outpatient basis.
You may qualify if:
- Adults, men and women, 18 y/o or more
- Patient diagnosed COVID positive with RT-PCR positive or very suggestive symptoms and a contagion (contact with sick subjects) that can be managed on an outpatient basis.
- Patient in possession of a smartphone (with Android or iOS) allowing the installation of the Withings Health Mate application
- Patient with access to an internet connection for the use of Withings connected products at the containment site
- Voluntary patient who has not objected to his or her participation
- Patient affiliated to or beneficiary of a social security scheme
You may not qualify if:
- Pregnant Women
- Patient with severe symptoms requiring hospitalization as recommended by the French Ministry of Health (23/03/2020)
- Patient without social protection or affiliated to the AME (State Medical Aid)
- Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curatorship) Articles L1121-5 to L1121-8
- Patient who, in the judgment of the investigator, may not be cooperative or respectful of the obligations inherent to participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Withingslead
Study Sites (4)
CHU Grenoble-Alpes
Grenoble, Auvergne-Rhône-Alpes, 38043, France
CHU d'Amiens
Amiens, Hauts-de-France, 80054, France
Hôpital d'Instruction des Armées Percy
Clamart, Île-de-France Region, 92140, France
Hôpital d'Instruction des Armées Bégin
Saint-Mandé, Île-de-France Region, 94160, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Louis Pépin, Pr
CHU Grenoble Alpes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2020
First Posted
September 23, 2020
Study Start
September 14, 2020
Primary Completion
January 12, 2021
Study Completion
May 12, 2021
Last Updated
May 20, 2021
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share